New Drugs on the Block—Emerging Treatments for Nonalcoholic Steatohepatitis

Patients with nonalcoholic steatohepatitis (NASH) are at higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications. When addressing treatment of NASH, we have limited approved options, and the mainstay of therapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojsavljevic-Shapeski, Sanja, Duvnjak, Marko, Virovic-Jukic, Lucija, Hrabar, Davor, Smircic Duvnjak, Lea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868699/
https://www.ncbi.nlm.nih.gov/pubmed/33604255
http://dx.doi.org/10.14218/JCTH.2020.00057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868699/
https://www.ncbi.nlm.nih.gov/pubmed/33604255
http://dx.doi.org/10.14218/JCTH.2020.00057

Ejemplares similares